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Appendix S1: Selection of effectiveness data and transformation for use in the 
economic analysis 
 
Effectiveness data were obtained from a systematic literature review and network meta-
analyses (NMAs) of randomised clinical trials (RCTs) of psychological and psychosocial 
interventions for children and young people with clinically important PTSD symptoms 
(Mavranezouli et al., 2019). The NMAs were conducted within a Bayesian framework using 
Markov Chain Monte Carlo simulation techniques implemented in WinBUGS 1.4.3 (Lunn, 
Thomas, Best, & Spiegelhalter, 2000; Spiegelhalter, Thomas, Best, & Lunn, 2003). 
 
The NMAs included 2 analyses of changes in PTSD symptom scores (between baseline and 
treatment endpoint; and between baseline and 1-4 month follow-up) and one analysis of 
dichotomous remission data at treatment endpoint. Although dichotomous data are more 
suitable for use in economic modelling as they can be easily translated into probabilities of 
events that correspond directly to the model health states, available dichotomous remission 
data were sparse and did not cover all interventions of interest in the economic analysis (9 
RCTs assessing 7 treatment options reported dichotomous remission at treatment endpoint; 
in contrast, continuous PTSD symptom change score data between baseline and treatment 
endpoint were available for 17 treatment options in 29 RCTs). Therefore, the economic 
analysis utilised the results of the NMAs of changes in PTSD symptom scores, which were 
reported as standardised mean differences (SMDs), and were subsequently transformed into 
log-odds ratios (LORs) of effect (Chinn, 2000), so that they could be utilised in the economic 
analysis, as described in our companion paper (Mavranezouli et al., 2019; Appendix S3). 
 
The log-odds ratios of remission of each intervention versus no treatment (which served as 
the baseline treatment) were exponentiated into odds ratios. Subsequently, the probability of 
remission for each intervention, which was utilised in the economic model, was estimated 




𝑖𝑛𝑡𝑒𝑟𝑣𝑒𝑛𝑡𝑖𝑜𝑛 𝑝𝑟𝑜𝑏 =  
𝑜𝑑𝑑𝑠
(1+𝑜𝑑𝑑𝑠)
  (1) 
and 
𝑜𝑑𝑑𝑠 =  
𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒 𝑝𝑟𝑜𝑏
(1−𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒 𝑝𝑟𝑜𝑏) 
 𝑂𝑅 (2) 
where baseline prob is the probability of remission for the baseline treatment (no treatment), 
OR is the odds ratio of remission for each intervention versus no treatment as estimated 
following exponentiation of the log-odds ratios obtained from the NMA, and odds is the odds 
of each intervention to achieve remission.  
 
The NMA models were run in WinBUGS with an initial burn-in period of 100,000 iterations, 
followed by 300,000 further iterations, thinned by 30 so as to obtain 10,000 iterations for use 
in the economic model. These 10,000 samples are representative of the full posterior 









Appendix S2: Estimation of the baseline probability of remission 
 
The probability of remission for no treatment (baseline) was obtained from a study reporting 
long-term data on the course of PTSD derived from 1575 people with lifetime PTSD who had 
participated in 22 World Health Organization (WHO) World Mental Health surveys (Rosellini 
et al., 2018). The study reported rates of remission of PTSD over 120 months (10 years) 
following PTSD onset for different age groups, including data on children aged 0-12 years 
and young people aged 13-24 years, in the form of a graph. Digital software 
(http://www.digitizeit.de) was used to read and extract the cumulative proportions of children 
aged 0-12 years and young people aged 13-24 years that remitted from PTSD at 3 months, 
6 months, 12 months, 24 months, and 36 months from PTSD onset. The values at each time 
point were averaged between the two age groups, to cover the whole range of the economic 
analysis study population. The extracted values were used to est imate the probability of 
remission between 0-3 months, 3-12 months, 12-24 months and 24-36 months in the model, 
conditional on not having achieved remission prior to the beginning of each interval. The 
estimated probabilities of remission during these time periods were subsequently 
transformed into 3-month probabilities that were used to inform the economic model.  
 
The table below shows the estimated cumulative probability of remission for children and 
young people at 3, 12, 24 and 36 months from PTSD onset; the probability of remission 
between 0-3, 3-12, 12-24 and 24-36 months (conditional on not having achieved remission 






Probability of remission over time in children and young people with PTSD, as 












the time interval* 
3 months 0.174 0-3 months 0.174 0.174 
12 months 0.370 3-12 months 0.238 0.087 
24 months 0.445 12-24 months 0.118 0.031 
36 months 0.500 24-36 months 0.100 0.026 
* conditional on not having achieved remission prior to the beginning of the interval 
 
The economic analysis evaluated interventions for the treatment of children and young 
people with PTSD initiated more than three months after a traumatic event. The economic 
model was thus assumed to start at month 3 from PTSD onset. Therefore, remission data 
corresponding to 0-3 months after PTSD onset were not used in the economic analysis. 
 
The estimated 3-month probability of remission over 3-12 months from PTSD onset informed 
months 0-9 of the economic model: these data were applied onto the no treatment arm. 
They also informed all model arms in months 3-6 of the economic model in the base-case 
analysis, and all model arms in months 6-9 in all analyses of the economic model, as the 
course of PTSD after 6 months of treatment was assumed to be independent of the 
treatment received. 
 
The 3-month probability of remission over 12-24 months from PTSD onset informed all 
model arms in months 9-21 of the economic model. The 3-month probability of remission 
over 24-36 months from PTSD onset informed all model arms in months 21-36 of the 
economic model; this 3-month probability was also utilised over the period of 36-39 months 





Appendix S3: Estimation of the unit cost of a clinical psychologist working for 
the National Health Service (NHS) in England [salary Band 7 according to the 
NHS Agenda for Change for qualified Allied Health Professionals] 
 
Cost element Unit cost (2017 price) Source 
Wages – salary (annual) £38,951 
Curtis & Burns, 2017; unit cost of 
community-based scientific & 
professional staff, including allied health 
professionals (Agenda for Change band 
7) 
Salary on-costs (annual) £9,864 
Overheads – staff (annual) £11,960 
Overheads - non-staff 
(annual) 
£18,647 
Capital overheads (annual) £5,125 
Qualifications (total) £12,386 
Based on a mean clinical psychologist 
training cost estimate of £159,420 
(National College for Teaching and 
Leadership, 2016), annuitised using the 
formula reported in Netten, Knight, 
Dennett, Cooley, & Slight (1998), 
assuming a useful working life of 25 
years, a time from obtaining the 
qualification until retirement of 44 years, 
and an equal distribution of the useful 
working life over the period of 44 years 
due to lack of specific information on this 
distribution. 
Supervision (annual) £316 
Based on the unit cost of an Agenda for 
Change band 8a clinical psychologist 
(Curtis & Burns, 2017) providing 1.5 
hour of supervision per month, delivered 
in groups of 4 participants (British 
Association for Behavioural & Cognitive 
Psychotherapies, 2016 and expert 
advice); qualification costs included, as 
described above. 





42.6 weeks /year 
37.5 hours /week 
(1,599 hours) 
Curtis & Burns, 2017 
Total cost per hour £61  
Ratio of direct to indirect 
time* 
60:40 
assumption based on expert opinion and 
a review of respective ratios reported in 
the literature for clinical psychologists 
and other therapists delivering 
psychological interventions (Curtis & 
Burns, 2017) 








Appendix S4: Results of secondary probabilistic economic analyses 
 
Results of Scenario B [utility data from Gospodarevskaya (2013); beneficial effect up 















(at a threshold of 
£20,000/QALY) 
[TF-CBT] cognitive therapy 2.482  1,204   4,271   45,373   1.88  0.67 
[TF-CBT] Cohen TF-CBT / CPT 2.390  911   4,453   43,348   3.90  0.30 
[TF-CBT] group CBT 2.362  270   3,971   43,269   3.35  0.48 
[TF-CBT] narrative exposure 2.335  517   4,414   42,296   4.71  0.31 
Parent training 2.320  685   4,645   41,751   5.47  0.36 
[TF-CBT] exposure / PE 2.326  1,089   5,033   41,495   6.26  0.33 
Play therapy 2.297  719   4,840   41,094   6.31  0.46 
EMDR 2.268  461   4,731   40,636   6.65  0.62 
Supportive counselling 2.244  1,135   5,534   39,341   8.61  0.59 
Family therapy 2.169  287   5,135   38,245   9.12  0.56 
No treatment 2.121  0     5,114   37,312   9.76  1.00 
CPT: cognitive processing therapy; EMDR: eye movement desensitisation reprocessing; NMB: net 
monetary benefit; PE: prolonged exposure; Prob: probability of cost-effectiveness; TF-CBT: trauma-
focused cognitive behavioural therapy 
*estimated in a step-wise approach, according to which the most cost-effective intervention is omitted 
at each step, and the probability of cost-effectiveness of the next most cost-effective intervention 
amongst the remaining treatment options is re-calculated 
 
 








Comparison across 11 alternative treatment options: supportive counselling, group CBT [TF-CBT], 
Cohen TF-CBT/ CPT [TF-CBT], cognitive therapy for PTSD [TF-CBT], narrative exposure therapy 
[TF-CBT], exposure/PE [TF-CBT], eye movement desensitisation and reprocessing (EMDR), family 








Comparison across 10 alternative treatment options: supportive counselling, group CBT [TF-CBT], 
Cohen TF-CBT/ CPT [TF-CBT], narrative exposure therapy [TF-CBT], exposure/PE [TF-CBT], eye 




Results of Scenario C [utility data from Shearer and colleagues (2018); no beneficial 















(at a threshold of 
£20,000/QALY) 
[TF-CBT] cognitive therapy 2.224  1,203   4,373   40,108   2.05  0.59 
[TF-CBT] narrative exposure 2.200  517   4,502   39,501   3.11  0.43 
Play therapy 2.196  715   4,843   39,075   4.85  0.31 
[TF-CBT] group CBT 2.184  270   4,807   38,872   5.05  0.21 
EMDR 2.187  459   4,908   38,824   5.59  0.28 
[TF-CBT] exposure / PE  2.196  1,089   5,221   38,700   6.47  0.25 
Parent training 2.187  682   5,112   38,635   6.61  0.36 
[TF-CBT] Cohen TF-CBT / CPT 2.191  911   5,202   38,622   6.66  0.52 
Family therapy 2.175  287   5,139   38,357   7.59  0.41 
No treatment 2.167  0     5,118   38,224   7.82  0.84 
Supportive counselling 2.177  1,137   5,911   37,631   10.21  1.00 
CPT: cognitive processing therapy; EMDR: eye movement desensitisation reprocessing; NMB: net 
monetary benefit; PE: prolonged exposure; Prob: probability of cost-effectiveness; TF-CBT: trauma-
focused cognitive behavioural therapy 
*estimated in a step-wise approach, according to which the most cost-effective intervention is omitted 
at each step, and the probability of cost-effectiveness of the next most cost-effective intervention 
















Comparison across 11 alternative treatment options: supportive counselling, group CBT [TF-CBT], 
Cohen TF-CBT/ CPT [TF-CBT], cognitive therapy for PTSD [TF-CBT], narrative exposure therapy 
[TF-CBT], exposure/PE [TF-CBT], eye movement desensitisation and reprocessing (EMDR), family 




Scenario C - Cost-effectiveness acceptability frontier - cognitive therapy for PTSD excluded 
from analysis 
 
Comparison across 10 alternative treatment options: supportive counselling, group CBT [TF-CBT], 
Cohen TF-CBT/ CPT [TF-CBT], narrative exposure therapy [TF-CBT], exposure/PE [TF-CBT], eye 




Results of Scenario D [utility data derived from Shearer and colleagues (2018); 















(at a threshold of 
£20,000/QALY) 
[TF-CBT] cognitive therapy 2.227  1,203   4,271   40,276   2.79  0.31 
[TF-CBT] group CBT 2.208  270   3,966   40,190   2.54  0.50 
[TF-CBT] Cohen TF-CBT / CPT 2.212  910   4,452   39,798   4.26  0.34 
[TF-CBT] narrative exposure 2.204  518   4,412   39,661   4.40  0.34 
Parent training 2.201  681   4,642   39,376   5.45  0.37 
EMDR 2.193  462   4,727   39,130   6.25  0.31 
Play therapy 2.197  718   4,833   39,113   6.40  0.44 
[TF-CBT] exposure / PE 2.202  1,087   5,035   39,004   7.02  0.57 
Family therapy 2.176  287   5,132   38,395   8.68  0.32 
No treatment 2.169  0     5,113   38,261   8.88  0.55 
Supportive counselling 2.189  1,136   5,529   38,244   9.32  1.00 
CPT: cognitive processing therapy; EMDR: eye movement desensitisation reprocessing; NMB: net 
monetary benefit; PE: prolonged exposure; Prob: probability of cost-effectiveness; TF-CBT: trauma-
focused cognitive behavioural therapy 
*estimated in a step-wise approach, according to which the most cost-effective intervention is omitted 
at each step, and the probability of cost-effectiveness of the next most cost-effective intervention 
















Comparison across 11 alternative treatment options: supportive counselling, group CBT [TF-CBT], 
Cohen TF-CBT/ CPT [TF-CBT], cognitive therapy for PTSD [TF-CBT], narrative exposure therapy 
[TF-CBT], exposure/PE [TF-CBT], eye movement desensitisation and reprocessing (EMDR), family 




Scenario D - Cost-effectiveness acceptability frontier - cognitive therapy for PTSD excluded 
from analysis 
 
Comparison across 10 alternative treatment options: supportive counselling, group CBT [TF-CBT], 
Cohen TF-CBT/ CPT [TF-CBT], narrative exposure therapy [TF-CBT], exposure/PE [TF-CBT], eye 




Appendix S5: Results of deterministic sensitivity analyses 
 
Scenario A [utility data from Gospodarevskaya (2013); no beneficial effect beyond treatment endpoint] 
 
 










[TF-CBT] cognitive therapy 43,790 [TF-CBT] cognitive therapy  45,324  [TF-CBT] cognitive therapy  42,375  
[TF-CBT] narrative exposure  41,256 [TF-CBT] narrative exposure   42,310  [TF-CBT] narrative exposure   40,279  
Play therapy 40,209 Play therapy  41,175  Play therapy  39,314  
[TF-CBT] exposure / PE  39,782 [TF-CBT] exposure / PE   40,744  [TF-CBT] exposure / PE   38,889  
[TF-CBT] Cohen TF-CBT / CPT 39,265 [TF-CBT] Cohen TF-CBT / CPT  40,127  [TF-CBT] group CBT  38,466  
[TF-CBT] group CBT 39,129 EMDR  39,885  [TF-CBT] Cohen TF-CBT / CPT  38,464  
EMDR  39,127 [TF-CBT] group CBT  39,841  EMDR  38,421  
Parent training 38,728 Parent training  39,473  Parent training  38,034  
Family therapy 37,457 Family therapy  37,939  Family therapy  37,004  
No treatment 37,075 No treatment  37,464  No treatment  36,708  
Supportive counselling 36,823 Supportive counselling  37,388  Supportive counselling  36,294  
CPT: cognitive processing therapy; EMDR: eye movement desensitisation reprocessing; NMB: net monetary benefit; PE: prolonged exposure; TF-






Scenario B [utility data from Gospodarevskaya (2013); beneficial effect up to 3-month follow-up] 
 
 










[TF-CBT] cognitive therapy  44,079  [TF-CBT] cognitive therapy  45,637  [TF-CBT] cognitive therapy  42,639  
[TF-CBT] group CBT  42,684  [TF-CBT] group CBT  43,747  [TF-CBT] group CBT  41,687  
[TF-CBT] Cohen TF-CBT / CPT  42,534  [TF-CBT] Cohen TF-CBT / CPT  43,680  [TF-CBT] Cohen TF-CBT / CPT  41,459  
[TF-CBT] narrative exposure  40,919  [TF-CBT] narrative exposure  41,931  [TF-CBT] narrative exposure  39,981  
Parent training  40,258  Play therapy  41,175  Parent training  39,471  
Play therapy  40,209  Parent training  41,095  Play therapy  39,314  
[TF-CBT] exposure / PE  39,454  [TF-CBT] exposure / PE  40,301  [TF-CBT] exposure / PE  38,723  
EMDR  38,722  EMDR  39,329  EMDR  38,150  
Supportive counselling  38,247  Supportive counselling  38,929  Supportive counselling  37,605  
Family therapy  37,457  Family therapy  37,939  Family therapy  37,004  
No treatment  37,075  No treatment  37,464  No treatment  36,708  
CPT: cognitive processing therapy; EMDR: eye movement desensitisation reprocessing; NMB: net monetary benefit; PE: prolonged exposure; TF-






Scenario C [utility data from Shearer and colleagues (2018); no beneficial effect beyond treatment endpoint] 
 
 










[TF-CBT] cognitive therapy  39,791  [TF-CBT] cognitive therapy  40,385  [TF-CBT] cognitive therapy  39,243  
[TF-CBT] narrative exposure  39,405  [TF-CBT] narrative exposure  39,813  [TF-CBT] narrative exposure  39,027  
[TF-CBT] group CBT   38,814  Play therapy  39,132  [TF-CBT] group CBT   38,558  
Play therapy   38,758  [TF-CBT] group CBT  39,090  Play therapy   38,411  
EMDR  38,603  EMDR  38,897  EMDR  38,330  
[TF-CBT] exposure / PE  38,344  [TF-CBT] exposure / PE  38,717  No treatment  38,067  
[TF-CBT] Cohen TF-CBT / CPT   38,276  [TF-CBT] Cohen TF-CBT / CPT   38,610  [TF-CBT] exposure / PE  37,999  
Parent training  38,263  Parent training  38,552  Family therapy  37,999  
No treatment   38,209  Family therapy  38,361  Parent training  37,994  
Family therapy  38,174  No treatment  38,360  [TF-CBT] Cohen TF-CBT / CPT  37,966  
Supportive counselling  37,166  Supportive counselling  37,385  Supportive counselling  36,962  
CPT: cognitive processing therapy; EMDR: eye movement desensitisation reprocessing; NMB: net monetary benefit; PE: prolonged exposure; TF-





Scenario D [utility data from Shearer and colleagues (2018); beneficial effect up to 3-month follow-up] 
 
 










[TF-CBT] group CBT   40,191  [TF-CBT] group CBT   40,602  [TF-CBT] group CBT   39,805  
[TF-CBT] cognitive therapy  39,903  [TF-CBT] cognitive therapy  40,506  [TF-CBT] cognitive therapy  39,345  
[TF-CBT] Cohen TF-CBT / CPT  39,542  [TF-CBT] Cohen TF-CBT / CPT  39,985  [TF-CBT] Cohen TF-CBT / CPT  39,126  
[TF-CBT] narrative exposure  39,275  [TF-CBT] narrative exposure  39,667  [TF-CBT] narrative exposure  38,911  
Parent training  38,855  Parent training  39,180  Parent training  38,551  
Play therapy   38,758  Play therapy   39,132  Play therapy   38,411  
EMDR  38,446  EMDR  38,681  EMDR  38,225  
[TF-CBT] exposure / PE  38,218  [TF-CBT] exposure / PE  38,545  No treatment  38,067  
No treatment   38,209  Family therapy  38,361  Family therapy  37,999  
Family therapy  38,174  No treatment  38,360  [TF-CBT] exposure / PE  37,934  
Supportive counselling  37,718  Supportive counselling  37,982  Supportive counselling  37,469  
CPT: cognitive processing therapy; EMDR: eye movement desensitisation reprocessing; NMB: net monetary benefit; PE: prolonged exposure; TF-
CBT: trauma-focused cognitive behavioural therapy 
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